[go: up one dir, main page]

BR9915589A - Use of unsubstituted azabicycloalkane derivatives - Google Patents

Use of unsubstituted azabicycloalkane derivatives

Info

Publication number
BR9915589A
BR9915589A BR9915589-3A BR9915589A BR9915589A BR 9915589 A BR9915589 A BR 9915589A BR 9915589 A BR9915589 A BR 9915589A BR 9915589 A BR9915589 A BR 9915589A
Authority
BR
Brazil
Prior art keywords
unsubstituted
derivatives
azabicycloalkane derivatives
azabicycloalkane
substituted
Prior art date
Application number
BR9915589-3A
Other languages
Portuguese (pt)
Inventor
Rainer Munschauer
Gerd Steiner
Gerhard Gross
Martin Traut
Liliane Unger
Hans-J Rgen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR9915589A publication Critical patent/BR9915589A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)

Abstract

"USO DE DERIVADOS DE AZABICICLOALCANO N-SUBSTITUìDO" Esta invenção refere-se ao uso de derivados de 3-azabicicloalcano N-substituído da fórmula (I). em que B, R¹, R² e n têm os significados dados na descrição, para combater doenças de vício e outras doenças do sistema nervoso central."USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES" This invention relates to the use of N-substituted 3-azabicycloalkane derivatives of formula (I). where B, R¹, R² and n have the meanings given in the description, to combat diseases of addiction and other diseases of the central nervous system.

BR9915589-3A 1998-11-24 1999-11-12 Use of unsubstituted azabicycloalkane derivatives BR9915589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (en) 1998-11-24 1998-11-24 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
PCT/EP1999/008734 WO2000030639A1 (en) 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Publications (1)

Publication Number Publication Date
BR9915589A true BR9915589A (en) 2001-08-07

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9915589-3A BR9915589A (en) 1998-11-24 1999-11-12 Use of unsubstituted azabicycloalkane derivatives

Country Status (21)

Country Link
EP (1) EP1133293A1 (en)
JP (1) JP2002530333A (en)
KR (1) KR20010080535A (en)
CN (1) CN1328455A (en)
AR (1) AR021502A1 (en)
AU (1) AU1775300A (en)
BG (1) BG105549A (en)
BR (1) BR9915589A (en)
CA (1) CA2352526A1 (en)
CZ (1) CZ20011796A3 (en)
DE (1) DE19854147A1 (en)
HK (1) HK1040933A1 (en)
HR (1) HRP20010472A2 (en)
HU (1) HUP0104416A3 (en)
IL (1) IL143181A0 (en)
NO (1) NO20012538L (en)
PL (1) PL348758A1 (en)
SK (1) SK7112001A3 (en)
TR (1) TR200101476T2 (en)
WO (1) WO2000030639A1 (en)
ZA (1) ZA200103976B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (en) 2004-12-13 2009-11-03 Lilly Co Eli single compound or stereoisomers, mixtures of pharmaceutically acceptable stereoisomers, salts, tautomers or prodrugs thereof, pharmaceutical composition, and use of a compound
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
CN105246485B (en) * 2013-01-15 2019-03-15 诺华有限公司 Application of α7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE4427647A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use

Also Published As

Publication number Publication date
JP2002530333A (en) 2002-09-17
BG105549A (en) 2001-12-29
KR20010080535A (en) 2001-08-22
WO2000030639A1 (en) 2000-06-02
CN1328455A (en) 2001-12-26
HRP20010472A2 (en) 2003-04-30
DE19854147A1 (en) 2000-05-25
EP1133293A1 (en) 2001-09-19
HUP0104416A3 (en) 2002-11-28
ZA200103976B (en) 2002-05-16
NO20012538D0 (en) 2001-05-23
SK7112001A3 (en) 2001-12-03
CZ20011796A3 (en) 2002-05-15
NO20012538L (en) 2001-07-04
CA2352526A1 (en) 2000-06-02
AR021502A1 (en) 2002-07-24
TR200101476T2 (en) 2001-10-22
IL143181A0 (en) 2002-04-21
HUP0104416A2 (en) 2002-04-29
PL348758A1 (en) 2002-06-03
AU1775300A (en) 2000-06-13
HK1040933A1 (en) 2002-06-28

Similar Documents

Publication Publication Date Title
BR9806752A (en) Phthalazinones.
BR9713734A (en) Sulfonamide derivatives, process for their preparation, and their use as medicines
BRPI0007487B8 (en) diphenyl-ureas substituted with w-carboxy-aryls as raf kinase inhibitors
ES2195970T3 (en) L-RIBAVIRINA AND USES OF THE SAME.
PT1233973E (en) ADENOSIN DERIVATIVES 5'-TIO-SUBSTITUTED NON-HETEROCYCLICS PARTIAL OR TOTAL AGENTS OF A1
TR200000782T2 (en) Resorcinol derivatives.
BR9814040A (en) Acute lung with fibrosis with avb6 antagonists
BR9910029A (en) Hydroxy indols, their application as phosphodiesterase 4 inhibitors and process for their preparation
BR0007527A (en) Phenylphenanthridines with IV-dependent inhibitory activity
ES2052629T3 (en) PIRAZOLO (3,4-D) PIRIDINES, PROCEDURE FOR ITS PREPARATION AND USE AS MEDICINES.
IT1285770B1 (en) CORTICOID COMPOUNDS
BR9910032A (en) Thienopyrimidines
FI944770A0 (en) Substituted 1-naphthylpyrazole-3-carboxyamides acting on neurotensin, their preparation and pharmaceutical compositions containing them
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
CO4940430A1 (en) POLYCLIC COMPOUNDS CONTAINING HYDROGENATED STAUROSPORIN WITH CONVENIENT PHARMACOLOGICAL PROPERTIES AND AN INHIBITING EFFECT ON THE GROWTH OF TUMOR CELLS
AR009809A1 (en) DERIVATIVES OF 10,13,15-TRIOXATRICICLO [9.2.1 (9.6)] - PENTADECANONE, PROCEDURES FOR ITS PREPARATION AND MEDICINES CONTAINING THESE COMPOUNDS
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
DE59005313D1 (en) 2-methyl- and 2-hydroxymethyl-serine-N, N-diacetic acid and their derivatives.
BR0012169A (en) Dihydrobenzodiazepines and their use in the treatment of dyslipidemia
BR0111915A (en) 5-aminoalkylpyrazolo [4,3-d] pyrimidines
BR9712307A (en) Pyrazolinones for the treatment of weakened potency
BR9915589A (en) Use of unsubstituted azabicycloalkane derivatives
BR9908861A (en) Cyclooctadepsipeptides and their use to combat endoparasites
ES2016464A6 (en) Therapeutic uses of 2',5'-oligoadenylate derivatives.
BR0109589A (en) Pyrane [2,3-c] imidazo [-1,2-a] pyridine derivatives for the treatment of gastrointestinal disorders

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: ABBOTT GMBH & CO KG. (DE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007.